Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine

NCT01022021 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Rituximab
DRUG: Bendamustine

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]